The Pittsburgh Steelers could very well be looking for a Donte Jackson replacement in free agency in 2025 and one NFL analyst ...

The Minnesota Vikings have a future QB controversy on their hands and rumors about a JJ McCarthy trade are officially here.

Michael Salfino lays out his reasoning for who the Minnesota Vikings should choose as their QB of the future and who they ...

JPMorgan keeps an Overweight rating and $80 price target on Viking Therapeutics (VKTX) after the company announced that it has initiated the ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

The New York Giants will be in the market for their next franchise quarterback this offseason. While they’re widely expected ...

As Sam Darnold has become the latest quarterback to bounce back after an underwhelming stretch, the Vikings have both enjoyed ...

Viking Global Investors makes bold bets in finance sector with top holdings in US Bancorp, Visa, and Progressive Corp.

Viking Therapeutics Inc (VKTX) stock saw a modest uptick, ending the day at $42.68 which represents a slight increase of $0.33 or 0.78% from the prior close of $42.35. The stock opened at $41.94 and ...

Viking Therapeutics, Inc. (VKTX) closed the latest trading day at $42.68, indicating a +0.78% change from the previous session's end. This move outpaced the S&P 500's daily loss of 0.04%.